2024
DOI: 10.1016/j.ejphar.2023.176236
|View full text |Cite
|
Sign up to set email alerts
|

Salidroside attenuates myocardial remodeling in DOCA-salt-induced mice by inhibiting the endothelin 1 and PI3K/AKT/NFκB signaling pathways

Qiao Liu,
Qingman Luo,
Bin Zhong
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 50 publications
0
1
0
Order By: Relevance
“…Treatments with ET A antagonists such as bosentan and BQ-123 have been shown to improve the cardiac function and survival of heart failure subjects [230]. Several endothelin-1 receptor blockers [197,231] and salidroside, an antioxidant [232], have also been demonstrated to inhibit adverse cardiac remodeling in heart failure. A schematic representation of events for the development of cardiac hypertrophy and heart failure due to endothelin-1 is shown in Figure 5.…”
Section: Role Of Endothelin-1 In Cardiac Hypertrophy and Heart Failurementioning
confidence: 99%
“…Treatments with ET A antagonists such as bosentan and BQ-123 have been shown to improve the cardiac function and survival of heart failure subjects [230]. Several endothelin-1 receptor blockers [197,231] and salidroside, an antioxidant [232], have also been demonstrated to inhibit adverse cardiac remodeling in heart failure. A schematic representation of events for the development of cardiac hypertrophy and heart failure due to endothelin-1 is shown in Figure 5.…”
Section: Role Of Endothelin-1 In Cardiac Hypertrophy and Heart Failurementioning
confidence: 99%